dc.creator | Ampatzidou M., Paterakis G., Vasdekis V., Papadhimitriou S.I., Papadakis V., Vassilopoulos G., Polychronopoulou S. | en |
dc.date.accessioned | 2023-01-31T07:31:12Z | |
dc.date.available | 2023-01-31T07:31:12Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1080/10428194.2018.1471603 | |
dc.identifier.issn | 10428194 | |
dc.identifier.uri | http://hdl.handle.net/11615/70494 | |
dc.description.abstract | [No abstract available] | en |
dc.language.iso | en | en |
dc.source | Leukemia and Lymphoma | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049564380&doi=10.1080%2f10428194.2018.1471603&partnerID=40&md5=c6f5275a21e4ac84a5320a59bbb1b8b6 | |
dc.subject | acute lymphoblastic leukemia | en |
dc.subject | adolescent | en |
dc.subject | cancer prognosis | en |
dc.subject | cancer survival | en |
dc.subject | child | en |
dc.subject | childhood leukemia | en |
dc.subject | controlled study | en |
dc.subject | event free survival | en |
dc.subject | female | en |
dc.subject | flow cytometry | en |
dc.subject | human | en |
dc.subject | human tissue | en |
dc.subject | Letter | en |
dc.subject | major clinical study | en |
dc.subject | male | en |
dc.subject | minimal residual disease | en |
dc.subject | overall survival | en |
dc.subject | priority journal | en |
dc.subject | recurrence free survival | en |
dc.subject | retrospective study | en |
dc.subject | survival rate | en |
dc.subject | survival time | en |
dc.subject | acute lymphoblastic leukemia | en |
dc.subject | bone marrow | en |
dc.subject | diagnosis | en |
dc.subject | disease free survival | en |
dc.subject | follow up | en |
dc.subject | infant | en |
dc.subject | minimal residual disease | en |
dc.subject | mortality | en |
dc.subject | pathology | en |
dc.subject | preschool child | en |
dc.subject | prognosis | en |
dc.subject | survival analysis | en |
dc.subject | time factor | en |
dc.subject | tumor recurrence | en |
dc.subject | Adolescent | en |
dc.subject | Bone Marrow | en |
dc.subject | Child | en |
dc.subject | Child, Preschool | en |
dc.subject | Disease-Free Survival | en |
dc.subject | Female | en |
dc.subject | Flow Cytometry | en |
dc.subject | Follow-Up Studies | en |
dc.subject | Humans | en |
dc.subject | Infant | en |
dc.subject | Male | en |
dc.subject | Neoplasm Recurrence, Local | en |
dc.subject | Neoplasm, Residual | en |
dc.subject | Precursor Cell Lymphoblastic Leukemia-Lymphoma | en |
dc.subject | Prognosis | en |
dc.subject | Survival Analysis | en |
dc.subject | Time Factors | en |
dc.subject | Taylor and Francis Ltd | en |
dc.title | Prognostic significance of flow cytometry MRD log reduction during induction treatment of childhood ALL | en |
dc.type | other | en |